For all three viruses (CMV, EBV, and HHV‐6), we did not observe any statistically significant differences in IgG and IgM positivity rates between ME/CFS patients and control group (P = .0601‐1, for tested serological markers). This evidence concerns the gene CD40LG and myalgic encephalomeyelitis/chronic fatigue syndrome.